These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15584126

  • 1. ACE inhibitors reduce heart-related death in type 2 diabetics.
    Health News; 2004 Oct; 10(10):15. PubMed ID: 15584126
    [No Abstract] [Full Text] [Related]

  • 2. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M, Amann FW, Salomon F.
    Schweiz Med Wochenschr; 1999 May 08; 129(18):700-6. PubMed ID: 10407943
    [Abstract] [Full Text] [Related]

  • 3. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA, Molnar J, Arora RR.
    Diabetes Obes Metab; 2008 Jan 08; 10(1):41-52. PubMed ID: 18095949
    [Abstract] [Full Text] [Related]

  • 4. [Ramipril and new therapeutic possibilities for ACE-inhibitors].
    Vespasiani Gentilucci U, Picardi A.
    Clin Ter; 2000 Jan 08; 151(4):307-8. PubMed ID: 11107682
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HOPE for all people with diabetes? Heart Outcomes Prevention Evaluation.
    Marshall SM.
    Diabet Med; 2000 Sep 08; 17 Suppl 2():9-10. PubMed ID: 11048826
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serious cardiovascular outcomes in diabetes: the role of hypoglycemia.
    Yakubovich N, Gerstein HC.
    Circulation; 2011 Jan 25; 123(3):342-8. PubMed ID: 21263007
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacological prevention of late complications of diabetes].
    Jensen TJ, Hilsted JC.
    Ugeskr Laeger; 1996 Apr 22; 158(17):2402-3. PubMed ID: 8685997
    [No Abstract] [Full Text] [Related]

  • 15. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke.
    Schelleman H, Klungel OH, Witteman JC, Breteler MM, Hofman A, van Duijn CM, de Boer A, Stricker BH.
    Pharmacogenomics J; 2008 Dec 22; 8(6):400-7. PubMed ID: 18347611
    [Abstract] [Full Text] [Related]

  • 16. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):726-33. PubMed ID: 16487836
    [Abstract] [Full Text] [Related]

  • 17. Renin-angiotensin-system blockade in the prevention of diabetes.
    Ostergren J.
    Diabetes Res Clin Pract; 2007 May 21; 76 Suppl 1():S13-21. PubMed ID: 17320999
    [Abstract] [Full Text] [Related]

  • 18. [Late diagnosis. Only after myocardial infarction is diabetes discovered].
    MMW Fortschr Med; 2003 Feb 27; 145(9):56. PubMed ID: 12666536
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.